Recent

% | $
Quotes you view appear here for quick access.

công ty Cubist Pharmaceuticals Message Board

  • paggap2000 paggap2000 Apr 26, 2012 2:43 PM Flag

    Adolor contingency payment

    What is happening to those Adolor contingency payments ?

    Any progress with FDA ?

    Thanks

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • bump

      • 1 Reply to cellmaverick
      • The terms:
        $1.25 per CPR payable if ADL5945 receives FDA approval for the treatment of chronic opioid induced constipation on or before July 1, 2019.
        An additional $1.75 per CPR payable if such FDA approval meets certain safety, efficacy, and timing criteria. This relates principally to ADL5945 having a clean, non-restrictive label.
        $0.50 payable if ADL5945 receives centralized EU approval for the treatment of OIC on or before July 1, 2019.
        An additional $1.00 per CPR payable if such centralized EU approval meets certain safety, efficacy, and timing criteria. This relates principally to ADL5945 having a clean, non-restrictive label.
        If, as of July 1, 2019, the Additional FDA Payment has not been earned, up to $1.75 per CPR payable if certain commercial milestones for ADL5495 are reached; and
        If, as of July 1, 2019, the Additional EMA Payment has not been earned, up to $1.00 per CPR payable if certain commercial milestones for ADL5495 are reached.

        Found this:
        Quotes via SeekingAlpha re CB-5945 (formerly ADL-5945)
        Phase 3 program to start by year-end 2012 - CBST would not reveal the cost of the program.
        Partnering discussions ongoing, no commitment regarding whether to partner before or after seeing phase 3 data.

        Have to watch news from cubist on cb 5945 although there's not much we can do but watch.

 
CBST
0.00(0.00%)